Coca-Cola will launch a version of its signature drink in the US made with cane sugar days after Donald Trump said he had spoken to the company about the move.The iconic beverage is sweetened with cane sugar in Mexico but has been made with high-fructose corn syrup in the US since the 1980s to save costs. However many US consumers, including Mr Trump, believe the Mexican version tastes better.The US president, known to be a big lover of both Coke and its diet variety, posted on his Truth Social platform las ...

McDonald's TodayMCDMcDonald's$289.24 -3.07 (-1.05%) 52-Week Range$243.53▼$326.32Dividend Yield2.45%P/E Ratio25.53Price Target$321.79Add to WatchlistMcDonald’s Corp. (NYSE: MCD) stock has declined by about 8% over the past month, as analysts are not particularly impressed with the company’s latest earnings report. Same-store sales, a critical metric for companies like McDonald's, fell by more than 2%. The reasons for the company’s recent struggles have been tied to the popularity of GLP-1 drugs, high prices ...

Group 1: S&P 500 and Russell Reconstitution - The S&P 500 index represents approximately 80% of the total U.S. equity market, making its quarterly rebalancing significant for investors [1] - The addition of stocks to the S&P 500 often leads to increased institutional buying, which can elevate stock prices, as seen with Palantir Technologies Inc. in 2024 [1] - Investors interested in small- to mid-cap stocks are focused on the Russell Reconstitution, which will conclude on June 27 [2] Group 2: Sprouts Farmers Market (SFM) - Sprouts Farmers Market Inc. has seen its stock increase over 500% in the last five years, aligning with the trend of health-conscious consumers [4] - The stock has a current price of $161.86, with a 12-month price forecast of $167.79, indicating a potential upside of 3.66% [4] - SFM's market cap is around $15 billion, and the stock has increased more than 100% in the last 12 months, despite being considered expensive with a P/E ratio over 25x compared to mainstream grocery stocks [6] Group 3: Insmed Inc. (INSM) - Insmed Inc. has experienced a stock price increase of over 47% in the last month due to positive Phase IIb trial data for its drug treating pulmonary arterial hypertension [9] - The current stock price is $99.46, with a 12-month price forecast of $104.81, suggesting a 5.38% upside [9] - Institutional buying has increased in the last two quarters, reflecting a more bullish analyst sentiment following the company's last earnings report [11] Group 4: FTAI Aviation Inc. (FTAI) - FTAI Aviation Inc. has climbed 8.9% in the last month, driven by increased demand for jet engine leasing and aftermarket services [12] - The stock has a current price of $130.08, with a 12-month price forecast of $171.83, indicating a potential upside of 32.10% [12] - Despite a recent rally, FTAI stock is still down over 10% in 2025, but analysts are raising their price targets, suggesting potential upside for investors [14]